Guobang Pharma Ltd (605507) — Free Cash Flow Generation Index
Guobang Pharma Ltd (605507) has a Free Cash Flow Generation Index of 0.64x as of September 2025. Free cash flow of CN¥200.68 Million represents 1% of operating cash flow (CN¥311.27 Million). See Guobang Pharma Ltd (605507) working capital ratio to evaluate short-term liquidity relative to the company's equity base.
FCF Generation Index
Free Cash Flow
Operating Cash Flow
Capital Expenditures
Guobang Pharma Ltd Free Cash Flow Generation Index (2017–2025)
Historical FCF Generation Index trend for Guobang Pharma Ltd across 8 annual periods. Explore debt repayment capacity of Guobang Pharma Ltd to assess how comfortably operating cash covers total debt obligations.
Annual Free Cash Flow Generation for Guobang Pharma Ltd (2017–2025)
Year-by-year Free Cash Flow Generation Index for Guobang Pharma Ltd. For the full company profile including market capitalisation, see Guobang Pharma Ltd market cap and net worth.
| Year | FCG Index | Free Cash Flow (CNY) | Operating CF | Capital Expenditures | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.50x | CN¥281.57 Million | CN¥559.28 Million | CN¥277.71 Million | ▲ +23.8% |
| 2024 | 0.41x | CN¥287.29 Million | CN¥706.41 Million | CN¥419.12 Million | ▲ +190.7% |
| 2023 | -0.45x | CN¥-231.68 Million | CN¥516.76 Million | CN¥748.44 Million | ▼ -313.2% |
| 2022 | 0.21x | CN¥213.92 Million | CN¥1.02 Billion | CN¥803.12 Million | ▼ -34.8% |
| 2020 | 0.32x | CN¥247.55 Million | CN¥767.70 Million | CN¥520.16 Million | ▲ +186.5% |
| 2019 | -0.37x | CN¥-164.32 Million | CN¥440.86 Million | CN¥605.18 Million | ▼ -153.3% |
| 2018 | 0.70x | CN¥378.44 Million | CN¥541.68 Million | CN¥163.24 Million | ▲ +582.3% |
| 2017 | -0.14x | CN¥-21.44 Million | CN¥148.03 Million | CN¥169.48 Million | — |